Hossein Khalili to Ritonavir
This is a "connection" page, showing publications Hossein Khalili has written about Ritonavir.
Connection Strength
0.146
-
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir. Daru. 2020 Dec; 28(2):625-634.
Score: 0.073
-
A Randomized Clinical Trial of the Efficacy and Safety of Interferon ß-1a in Treatment of Severe COVID-19. Antimicrob Agents Chemother. 2020 08 20; 64(9).
Score: 0.073